KEVIN C TANG Insider Trading $HRTX HERON THERAPEUTICS, INC. /DE/

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KEVIN C TANG.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KEVIN C TANG. KEVIN C TANG is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Chief Executive Officer in Odonate Therapeutics, Inc. ($ODT).

Over the past year KEVIN C TANG has been an insider in 3 companies. The total value of shares held by KEVIN C TANG in these companies amounts to $72,796,247.

KEVIN C TANG 10% Owner
Cyclacel Pharmaceuticals, Inc.
Director
HERON THERAPEUTICS, INC. /DE/
Director
LA JOLLA PHARMACEUTICAL CO
Chief Executive Officer
Odonate Therapeutics, Inc.
$ 72796247 The total value of shares held by KEVIN C TANG
Insider Rank

KEVIN C TANG ranks 618 out of 350,000 insiders. Go to Insider Ranking to see more.

KEVIN C TANG in HERON THERAPEUTICS, INC. /DE/

Trading Symbol: HRTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN C TANG: Director
Holdings: 5,830,215 shares
Latest Transaction: Dec 18 2018

Last 4 weeks trend: BUY
Last 3 months trend: BUY

Last 3 Months Overview:
Buy: 3x
Sell: 2x
Shares Bought: 3,901,324
Shares Sold: 2,938,639
Share Difference: +962,685
Value Difference: +$61,346,256

Latest Insider Trading Transactions of KEVIN C TANG in HERON THERAPEUTICS, INC. /DE/

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000001
Value of Purchases ($)0000005,000,008
No. of Sales0000001
Value of Sales ($)00000096,346,248

Sentiment: All, CYCC, HRTX, LJPC, ODT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 18 2018HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorOption ExerciseA24.9717,000424,49017,000
Sep 12 2018HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorSellS35.752,695,00096,346,2505,830,2158.5 M to 5.8 M (-31.61 %)
Apr 02 2018HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorBuyP26.00192,3085,000,0088,525,2158.3 M to 8.5 M (+2.31 %)
Dec 20 2017HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorOption ExerciseA17.0017,000289,00017,000
Jan 23 2017HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorBuyP12.202,459,01629,999,9958,332,9075.9 M to 8.3 M (+41.86 %)
Dec 23 2016HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorOption ExerciseA13.0017,000221,00017,000
Jun 20 2016HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorOption ExerciseM3.601,250,0004,500,0000
Jun 20 2016HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorPayment of ExerciseF18.47243,6394,500,0125,873,8916.1 M to 5.9 M (-3.98 %)
Jun 20 2016HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorBuyM3.601,250,0004,500,0006,117,5304.9 M to 6.1 M (+25.68 %)
Dec 24 2015HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorOption ExerciseA29.4117,000499,97017,000
Jun 12 2015HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorBuyP24.75121,2122,999,9974,867,5304.7 M to 4.9 M (+2.55 %)
Jun 02 2015HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorBuyP23.8432,395772,2944,746,3184.7 M to 4.7 M (+0.69 %)
Jun 02 2015HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorBuyP19.302,38045,9344,713,9234.7 M to 4.7 M (+0.05 %)
Jun 02 2015HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorBuyP19.74115,2252,274,0584,711,5434.6 M to 4.7 M (+2.51 %)

Page:   1